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New 'freatment Protocol for Feline Oral Squamous Cell Carcinoma
Squamous cell carcinoma is the most common
oropharyngeal tumor seen in the older cat. This very
aggressive disease is treatable by surgery in only about
50 percent of the patients because it involves the
tongue or irs base. The median survival rate from time
of diagnosis is one to three months because the
animals are eutbanized at that time because of the
inability to eat. The tumor is usually not diagnosed
until it has progressed substantially. Owners first
notice something is amiss when the cat is not
grooming itself and is reluctant to eat. This tumor is
very similar to advanced bead and neck cancer in
humans, which too has a very poor prognosis for
treatment. OnJy 15 to 30 percent of patients with
advanced bead and neck live five years or more after
diagnosis.
Dr. Sydney Evans. assistant professor of radi
ology at the School of Veterinary Medicine, Univer
sity of Pennsylvania, is investigating a treatment
protocol for feline oral squamous cell carcinoma,
using a new cell sensitizing drug and radiation
treatments. Cats with these tumors, when treated by
mdiation alone, have a median survival rate of four
months. "It bas long been suspected that the low
success rate of radiation treatment for these tumors
has been due to hypoxic tumor cells which are
radiation resistant," said Dr. Evans. ''Hypoxic cells
are oxygen poor and they are not easily killed by
radiation. One can make a hypoxic cell more receptve
i
to radiation by administering drugs which change the
cells' state of oxygenation." Unfortunately, these
drugs, when given in quantity, are neurotoxic and
cause damage to central and peripheral nerves.
Because this tumor in the cat can represent an animal
model for human head and neck cancer, new treat
ment modes used in animals can provide a great deal
of information for new treatment of human patients.
Dr. Evans and her colleagues studied the effects
of etanidazole when it is inJected directly into the
rumor bearing tissue to see whether this method
could improve the outcome of radiation therapy.
Eleven cats with measurable oral squamous cell
tumors were entered in the clinical study. Thoracic
radiographs were performed. as well as blood tests.
The tumors were biopsied and staged. Seven of the
cats also bad skull radiographs while four received an
MRl. Each cat received 12 radiation treatments, given
three times a week over 16 weeks. Between treatments
most of the animals were at home with their owners.
For each treatment the animals were anesthetized
so that they would remain still during radiation.
Thirty minutes prior to radiation treatment, the
tumor, as well as surrounding normal tissue, was
injected at 5 mm intervals with etanidazole. The first
four cats studied received the drug prior to every
other treatment. The fifth cat received the drug
injected into the tumor and intravenously on alternate
treatments. Because no significant toxicity was
observed. the amount of the drug injected was
increased for the remaining cats, and the drug was
administered prior to each radiation treatment.
In addition, pharmacokinetic studies were con
ducted in four cats. It was observed that drug levels in
the plasma peaked 14 minutes after intratumor
injection. Some of the patients developed self
limiting fevers and leukopenia (low white blood ceU
count). After radiation treatments ended, cats were
seen at regular intervals for examination and/or
biopsy of the tumor site.
In all cats, tumor regression occurred during the
course of therapy. In most cats this correlated with
the resolution of anorexia. return of grooming habits
and stabilization of weight. "The local tumor
response bas been encouraging, especially in those
cats with tongue squamous cell carcinoma," said Dr.
Evans. "For the six cats with the lesion of or under

evidence of local tumor progression. Five cats have
had local recurrence at 55, 125, l39, 202, and 331
days post treatment and have been euthanized. Three
cats died, one due to pulmonary metastases, pulmon
ary thromboembolism and pneumonia, one due to a
tracheal obstruction, and one due to osteonecrosis.
This can be compared to previous studies of radiation
alone, where the recurrence is reported at 46 to 142
days following diagnosis. Six animals were autopsied
and viable and necrotic rumor cells were found at the
treatment site.
'We chose to investigate the IT route of drug
administration because we expected it to result in an
optimal ratio of tumor response to normal tissue
toxicity, .. said Dr. Evans. "The IT route for radiosen
sitizers was of particular interest in light of previous
data which suggested that failure to improve outcome
resulted from the inability to achieve adequate tumor
drug levels before dose-limiting neurotoxicity.
•
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Th� sam� site after tl'eafment.

the tongue who completed the protocol, the median
time to progression and survival as of early Septem
ber was 122 days. This compares favorable with the
data from prvious studies in which the median
survival rate for cats with tongue squamous cell
carcinoma is 31 and 91 days respectively."
Of the 1 1 cats treated, three remain without

While this treatment does not offer a cure, it
does provide a longer quality Life for these feline
patients. When the tumor recurs, no further treat
ment is given and the animal is euthanized. Dr. Evans
said that "the present study had encouraged contin
ued technical and dosing modification of IT etanida
zole administration in feline squamous cell carcinoma
and other animal tumor models. While IT therapy
alone is promising as a route of administration in
easily accessible, well visuali.zed lesions, it may, in the
future, have an even more important role in supple
menting systemic administration, particularly of
bulky, hypoxic tumor sites." The study was a joint
project with the Fox Chase Cancer Institute. Jn
addition to Dr. Evans, Ur. Stuart Helland and Or.
Thomas Van Winkle, and Deborah Allen, from the
Veterinary School worked on the project.

Coping with Loss
It's 3:30 on a Thesday afternoon, and a small
group of sad4looking people are gathered in a room at
the School of Veterinary Medicine. There's the young
mother who, four weeks ago, bad her much-loved dog
eutbanized; it was leaking urine all over the bouse;
after a week of relief, the woman was dragged down
by an overwhelming guilt about her decision. and not
giving the dog a proper goodby. Her husband sits at
her side.
There's a woman whose 20-year-old cat
screamed every night, for no reason that bad ever
been diagnosed. The woman, whose apartment
echoes with quiet now, still feels badly that she didn't
comfort the cat when, riddled with cancer, it was put
to sleep; that was several months ago.
There's another woman who cried so hard when
her cat died that she burst a blood vessel in her lung
and bad to be hospitalized. This was the cat that had
sustained her when her husband died, 12 years ago;
the cat which had sat with her at the dinner table and
on the side of the bathtub, which had even accompan
ied her on a trip to Paris and cruised with her down
the Seine.
And what they're all doing is sharing tales about
the animals that they loved as dearly as people-and
whose deaths have left them with a hole in their Uves,
and a palpable grief that feels like it just won't let up.
"It's important to talk to people who have
animals," says Katb1een Dunn, M.S.W. a psychiatric
social worker at the University of Pennsylvania
School of Veterinary Medicine. She leads the Pet
Bereavement Support Group at the SchooL one of
.
few such groups in the United States. ''Other people
wiU tolerate you for a while, but then will often say

something hurting, like 'It was only an animal; why
not get anoth er one'? ' '
Although often incomprehensible to non-pet
'
owners, a pet s death can be as devastating as the
death of an important human being. "People some
times feel a sadness so terri ble that they think they'll
never get over it," says Dunn, who is "on call"
24-bours a day for emergency cases .
The reason for this pain is the depth of the bond
that's formed between most pet owners and their
animal companions. ·'What happens when you select
a pet is that you get very attached," Dunn says, "The
relationship consists of lots of love and joy and fun
- and, as I hear a lot, the uncondiHonal love you get
back from your pet. Because this bond is so deep, the
animal becomes a person to you, part of the family
sort of a perennial two-year-old. And if the relation
ship is threatened by death or illness, it's like a child
dying. It doesn't matter that what died was 'only' an
animal; a loss is a loss is a loss."
The death of an animal can also stir up the
memories of losing an important human being.
"Someone in the group might say; 'I'm feeling as
bad, or worse, than when my mother died," Dunn
says. The stages of the mourning and grieving process
that a pet owner goes through is analogous to the
process made famous by death-and-dying expert
Elizabeth Kubler-Ross. Pet owners often experience
anger, either at the veterinarian who couldn't "save"
their pet, or at themselves for not taking certain steps
that might have prevented their animal's demise. At
another point they may feel guilty, because they
didn't follow their veterinarian's advice exactly, or
because they chose to euthanize a failing animal that
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